🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How ‘Bout Them Dawgs!!! #JunkYardDawgs #GoDawgs

You've waited 41 years for this ... A celebration Dawg Nation will never forget❗️ Georgia Football 🐶🏆

Excited to share our article on management of ESBL UTIs. @sujitsuchindran @Albrechtazole K. Ashley Jones, PharmD, BCIDP Jesse Jacob academic.oup.com/ofid/article/9…

Congratulations🎉 to Dr. Daniel Anderson our Infectious Diseases/Internal Medicine pharmacist for his most recent publication! Way to go Daniel Anderson !! Follow the link below to read more. 🦠📰

Happy birthday to my beautiful wife! I love you @abseamon instagram.com/p/CaQ0XWtLdK97…

🔥 NEW in OFID 🔥 👥 Retrospective cohort of admitted patients with ESBL UTI 💊 non-carbapenem beta-lactams (NCBLs) vs. carbapenems Patients receiving NCBLs experienced: ☑️ no difference in LOS ☑️ higher rates of culture clearance ☑️ shorter DOTs 🔗 academic.oup.com/ofid/article/9…

A new study in OFID suggests that carbapenems may not be necessary in the treatment of patients with urinary tract infections caused by ESBL-producing organisms. 📄: bit.ly/3JAmWA1 #IDSAJournals #OpenForumInfectDis Paul Sax Jonathan Li Daniel Anderson

Thanks to Contagion for sharing our teams work on treating ESBL UTIs!

I see you Amber B Clemmons! Double Antibiotic Coverage Does Not Improve Outcomes in Febrile Neutropenia pharmacypracticenews.com/Clinical/Artic…

Thanks to the UGA College of Pharmacy students who make precepting such a joy! I’m humbled and honored to be recognized by this graduating class!

Is there an exception to #ShorterIsBetter for critically ill patients with Gram-negative BSI? Not according to our propensity-matched cohort study Josh Eudy Divisha Sharma Zoheb I. Sulaiman, DO Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 MCG ID Fellowship Wellstar MCG Health / UGA Pharmacy Residencies journals.sagepub.com/doi/10.1177/10…

🆕️🔥The largest real-world, multicenter study of dalbavancin use for Gram-positive BSI Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP Michael Rybak and many SIDP 🌟s Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection #IDXposts #DOTS link.springer.com/article/10.100…

We are delighted to announce the publication of UTI WikiGuideline in JAMA Network Open. Thank you to the 54 experts from 12 countries for drafting. Special thanks to Snacks, PharmD, MPH and Alfredo J Mena Lora MD FIDSA for leading the effort. jamanetwork.com/searchresults?…

This consensus statement creates a clinical guideline for the diagnosis and management of UTIs that addresses the gap between the evidence and recommendation strength. ja.ma/3UBBW90 @bradspellberg

Excited to present our UTI WikiGuidelines in JAMA Network Open. It was an honor to work with so many brilliant clinicians and an organization whose charter I so strongly believe in.